Daxor Corporation
Daxor Corporation engages in medical instrumentation and biotechnology operations. It develops the BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume, in conjunction with Volumex, a single-use radiopharmaceutical diagnostic injection and collection kit. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corpo… Read more
Daxor Corporation (DXR) - Net Assets
Latest net assets as of June 2025: $35.63 Million USD
Based on the latest financial reports, Daxor Corporation (DXR) has net assets worth $35.63 Million USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($35.90 Million) and total liabilities ($272.43K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $35.63 Million |
| % of Total Assets | 99.24% |
| Annual Growth Rate | 2.65% |
| 5-Year Change | 128.34% |
| 10-Year Change | 148.08% |
| Growth Volatility | 16.6 |
Daxor Corporation - Net Assets Trend (1985–2024)
This chart illustrates how Daxor Corporation's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Daxor Corporation (1985–2024)
The table below shows the annual net assets of Daxor Corporation from 1985 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $35.79 Million | +5.24% |
| 2023-12-31 | $34.01 Million | +17.40% |
| 2022-12-31 | $28.97 Million | +36.95% |
| 2021-12-31 | $21.15 Million | +34.94% |
| 2020-12-31 | $15.68 Million | +22.79% |
| 2019-12-31 | $12.77 Million | -2.27% |
| 2018-12-31 | $13.06 Million | -5.06% |
| 2017-12-31 | $13.76 Million | -10.34% |
| 2016-12-31 | $15.34 Million | +6.35% |
| 2015-12-31 | $14.43 Million | -41.31% |
| 2014-12-31 | $24.58 Million | -6.79% |
| 2013-12-31 | $26.37 Million | -24.90% |
| 2012-12-31 | $35.11 Million | -3.04% |
| 2011-12-31 | $36.22 Million | -22.94% |
| 2010-12-31 | $47.00 Million | -1.32% |
| 2009-12-31 | $47.63 Million | +9.58% |
| 2008-12-31 | $43.46 Million | -20.86% |
| 2007-12-31 | $54.92 Million | +20.33% |
| 2006-12-31 | $45.64 Million | +17.79% |
| 2005-12-31 | $38.74 Million | -2.85% |
| 2004-12-31 | $39.88 Million | +9.51% |
| 2003-12-31 | $36.42 Million | +8.56% |
| 2002-12-31 | $33.55 Million | -5.04% |
| 2001-12-31 | $35.33 Million | -8.64% |
| 2000-12-31 | $38.67 Million | +32.08% |
| 1999-12-31 | $29.28 Million | -17.06% |
| 1998-12-31 | $35.30 Million | +7.29% |
| 1997-12-31 | $32.90 Million | +3.46% |
| 1996-12-31 | $31.80 Million | -0.93% |
| 1995-12-31 | $32.10 Million | +3.22% |
| 1994-12-31 | $31.10 Million | +27.46% |
| 1993-12-31 | $24.40 Million | +9.42% |
| 1992-12-31 | $22.30 Million | +16.75% |
| 1991-12-31 | $19.10 Million | -9.05% |
| 1990-12-31 | $21.00 Million | +12.30% |
| 1989-12-31 | $18.70 Million | -1.58% |
| 1988-12-31 | $19.00 Million | +16.56% |
| 1987-12-31 | $16.30 Million | +13.99% |
| 1986-12-31 | $14.30 Million | +10.85% |
| 1985-12-31 | $12.90 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Daxor Corporation's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 510.2% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $25.63 Million | 71.61% |
| Common Stock | $54.09K | 0.15% |
| Other Components | $10.11 Million | 28.24% |
| Total Equity | $35.79 Million | 100.00% |
Daxor Corporation Competitors by Market Cap
The table below lists competitors of Daxor Corporation ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Long Time Technology Co., Ltd.
TWO:6555
|
$29.02 Million |
|
Ssangyong Information & Communications Corp
KQ:010280
|
$29.02 Million |
|
Hi Sharp Electronics Co Ltd
TWO:3128
|
$29.03 Million |
|
Finnovate Acquisition Corp
NASDAQ:FNVT
|
$29.03 Million |
|
Metavista3D Inc.
V:DDD
|
$29.00 Million |
|
Solarmax Technology Inc. Common Stock
NASDAQ:SMXT
|
$29.00 Million |
|
PEH Wertpapier AG
F:PEH
|
$28.98 Million |
|
Swift Haulage Bhd
KLSE:5303
|
$28.97 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Daxor Corporation's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 34,010,384 to 35,792,301, a change of 1,781,917 (5.2%).
- Net income of 536,334 contributed positively to equity growth.
- Other comprehensive income decreased equity by 25,093,122.
- Other factors increased equity by 26,338,705.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $536.33K | +1.5% |
| Other Comprehensive Income | $-25.09 Million | -70.11% |
| Other Changes | $26.34 Million | +73.59% |
| Total Change | $- | 5.24% |
Book Value vs Market Value Analysis
This analysis compares Daxor Corporation's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.54x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 4.40x to 1.54x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1985-12-31 | $2.59 | $11.39 | x |
| 1986-12-31 | $2.64 | $11.39 | x |
| 1987-12-31 | $2.89 | $11.39 | x |
| 1988-12-31 | $3.47 | $11.39 | x |
| 1989-12-31 | $3.28 | $11.39 | x |
| 1990-12-31 | $4.06 | $11.39 | x |
| 1991-12-31 | $3.52 | $11.39 | x |
| 1992-12-31 | $4.33 | $11.39 | x |
| 1993-12-31 | $4.66 | $11.39 | x |
| 1994-12-31 | $5.65 | $11.39 | x |
| 1995-12-31 | $6.42 | $11.39 | x |
| 1996-12-31 | $6.36 | $11.39 | x |
| 1997-12-31 | $6.58 | $11.39 | x |
| 1998-12-31 | $7.06 | $11.39 | x |
| 1999-12-31 | $5.86 | $11.39 | x |
| 2000-12-31 | $8.27 | $11.39 | x |
| 2001-12-31 | $7.57 | $11.39 | x |
| 2002-12-31 | $7.19 | $11.39 | x |
| 2003-12-31 | $7.84 | $11.39 | x |
| 2004-12-31 | $8.64 | $11.39 | x |
| 2005-12-31 | $8.35 | $11.39 | x |
| 2006-12-31 | $9.87 | $11.39 | x |
| 2007-12-31 | $12.01 | $11.39 | x |
| 2008-12-31 | $9.84 | $11.39 | x |
| 2009-12-31 | $11.12 | $11.39 | x |
| 2010-12-31 | $11.09 | $11.39 | x |
| 2011-12-31 | $8.58 | $11.39 | x |
| 2012-12-31 | $8.58 | $11.39 | x |
| 2013-12-31 | $6.42 | $11.39 | x |
| 2014-12-31 | $6.54 | $11.39 | x |
| 2015-12-31 | $3.75 | $11.39 | x |
| 2016-12-31 | $4.01 | $11.39 | x |
| 2017-12-31 | $3.65 | $11.39 | x |
| 2018-12-31 | $3.49 | $11.39 | x |
| 2019-12-31 | $3.05 | $11.39 | x |
| 2020-12-31 | $3.98 | $11.39 | x |
| 2021-12-31 | $5.24 | $11.39 | x |
| 2022-12-31 | $3.38 | $11.39 | x |
| 2023-12-31 | $7.34 | $11.39 | x |
| 2024-12-31 | $7.39 | $11.39 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Daxor Corporation utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 1.50%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 25.17%
- • Asset Turnover: 0.06x
- • Equity Multiplier: 1.02x
- Recent ROE (1.50%) is above the historical average (1.43%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1985 | 14.29% | 100.00% | 0.10x | 1.39x | $540.00K |
| 1986 | 11.35% | 88.89% | 0.08x | 1.51x | $190.00K |
| 1987 | 5.88% | 47.37% | 0.08x | 1.58x | $-630.00K |
| 1988 | 18.18% | 77.27% | 0.15x | 1.62x | $1.53 Million |
| 1989 | -2.75% | -22.73% | 0.08x | 1.46x | $-2.32 Million |
| 1990 | 13.81% | 63.04% | 0.14x | 1.53x | $800.00K |
| 1991 | -9.95% | -48.72% | 0.13x | 1.53x | $-3.81 Million |
| 1992 | 15.25% | 55.74% | 0.19x | 1.46x | $1.17 Million |
| 1993 | 9.02% | 45.83% | 0.16x | 1.19x | $-240.00K |
| 1994 | 6.16% | 39.13% | 0.13x | 1.20x | $-1.12 Million |
| 1995 | 4.05% | 27.66% | 0.12x | 1.17x | $-1.91 Million |
| 1996 | -0.31% | -3.57% | 0.08x | 1.17x | $-3.28 Million |
| 1997 | -0.61% | -40.00% | 0.01x | 1.26x | $-3.49 Million |
| 1998 | -1.13% | -133.33% | 0.01x | 1.25x | $-3.93 Million |
| 1999 | -0.33% | -16.88% | 0.02x | 1.22x | $-3.03 Million |
| 2000 | -0.14% | -7.40% | 0.02x | 1.28x | $-3.92 Million |
| 2001 | 0.85% | 39.47% | 0.02x | 1.23x | $-3.23 Million |
| 2002 | -0.58% | -7.17% | 0.06x | 1.24x | $-3.55 Million |
| 2003 | -2.96% | -34.00% | 0.07x | 1.33x | $-4.72 Million |
| 2004 | -1.45% | -47.63% | 0.02x | 1.40x | $-4.57 Million |
| 2005 | -3.45% | -99.44% | 0.02x | 1.54x | $-5.21 Million |
| 2006 | -1.72% | -52.85% | 0.02x | 1.71x | $-5.35 Million |
| 2007 | 19.39% | 569.44% | 0.02x | 1.87x | $5.16 Million |
| 2008 | 34.80% | 858.76% | 0.02x | 1.77x | $10.78 Million |
| 2009 | 12.23% | 344.78% | 0.02x | 1.58x | $1.06 Million |
| 2010 | 10.57% | 314.60% | 0.02x | 1.94x | $268.76K |
| 2011 | -19.84% | -562.51% | 0.01x | 2.37x | $-10.81 Million |
| 2012 | 3.38% | 0.00% | -0.04x | 1.60x | $-2.32 Million |
| 2013 | -31.16% | 0.00% | -0.24x | 1.80x | $-10.86 Million |
| 2014 | -3.97% | 0.00% | -0.09x | 1.87x | $-3.43 Million |
| 2015 | -63.40% | 0.00% | -0.36x | 1.45x | $-10.59 Million |
| 2016 | 9.49% | 79.32% | 0.09x | 1.34x | $-78.67K |
| 2017 | -9.01% | 0.00% | -0.05x | 1.40x | $-2.62 Million |
| 2018 | -6.78% | 0.00% | -0.05x | 1.35x | $-2.19 Million |
| 2019 | -3.88% | 0.00% | -0.01x | 1.11x | $-1.77 Million |
| 2020 | -10.88% | 0.00% | -0.06x | 1.06x | $-3.27 Million |
| 2021 | 22.45% | 81.57% | 0.23x | 1.18x | $2.63 Million |
| 2022 | 17.87% | 82.06% | 0.21x | 1.04x | $2.28 Million |
| 2023 | 0.83% | 0.81% | 0.99x | 1.03x | $-3.12 Million |
| 2024 | 1.50% | 25.17% | 0.06x | 1.02x | $-3.04 Million |
Industry Comparison
This section compares Daxor Corporation's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,683,526,542
- Average return on equity (ROE) among peers: -32.48%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Daxor Corporation (DXR) | $35.63 Million | 14.29% | 0.01x | $29.01 Million |
| ANGELALIGN TECHNOLOGY INC (AGLFF) | $480.24 Million | 2.52% | 0.41x | $405.57 Million |
| Akoya Biosciences Inc (AKYA) | $-30.16 Million | 0.00% | 0.00x | $16.24 Million |
| Alcon AG (ALC) | $19.68 Billion | 1.70% | 0.48x | $37.82 Billion |
| Align Technology Inc (ALGN) | $3.85 Billion | 10.94% | 0.61x | $11.75 Billion |
| AngioDynamics Inc (ANGO) | $355.71 Million | 3.06% | 0.15x | $354.40 Million |
| Ansell Limited (ANSLF) | $386.33 Million | -0.45% | 0.87x | $2.58 Billion |
| AptarGroup Inc (ATR) | $2.07 Billion | 11.57% | 1.03x | $8.27 Billion |
| AtriCure Inc (ATRC) | $72.60 Million | -15.79% | 0.54x | $1.42 Billion |
| Avinger Inc (AVGR) | $-35.69 Million | 0.00% | 0.00x | $1.26 Million |
| Anteris Technologies Global Corp. Common Stock (AVR) | $9.03 Million | -338.35% | 0.77x | $156.14 Million |